These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12833517)

  • 101. Mass spectrometry and proteomics.
    Patterson SD
    Physiol Genomics; 2000 Mar; 2(2):59-65. PubMed ID: 11015583
    [No Abstract]   [Full Text] [Related]  

  • 102. Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin.
    Reichel C; Thevis M
    Bioanalysis; 2013 Mar; 5(5):587-602. PubMed ID: 23425274
    [TBL] [Abstract][Full Text] [Related]  

  • 103. In vitro bioassay for human erythropoietin based on proliferative stimulation of an erythroid cell line and analysis of carbohydrate-dependent microheterogeneity.
    Hammerling U; Kroon R; Wilhelmsen T; Sjödin L
    J Pharm Biomed Anal; 1996 Aug; 14(11):1455-69. PubMed ID: 8877851
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Mass spectrometry-based approaches for the detection of proteins of Staphylococcus species.
    Ho YP; Reddy PM
    Infect Disord Drug Targets; 2008 Sep; 8(3):166-82. PubMed ID: 18782034
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Mass spectrometric characterisation of darbepoetin alfa biosimilars with C-terminal arginine residues.
    Okano M; Sato M; Kageyama S
    Drug Test Anal; 2016 Nov; 8(11-12):1138-1146. PubMed ID: 27706921
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Quality of original and biosimilar epoetin products.
    Brinks V; Hawe A; Basmeleh AH; Joachin-Rodriguez L; Haselberg R; Somsen GW; Jiskoot W; Schellekens H
    Pharm Res; 2011 Feb; 28(2):386-93. PubMed ID: 20886265
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Multivariate statistics for the differentiation of erythropoietin preparations based on intact glycoforms determined by CE-MS.
    Taichrib A; Pioch M; Neusüß C
    Anal Bioanal Chem; 2012 May; 403(3):797-805. PubMed ID: 22430131
    [TBL] [Abstract][Full Text] [Related]  

  • 108. High-performance anion-exchange chromatography combined with intrinsic fluorescence detection to determine erythropoietin in pharmaceutical products.
    Luykx DM; Dingemanse PJ; Goerdayal SS; Jongen PM
    J Chromatogr A; 2005 Jun; 1078(1-2):113-9. PubMed ID: 16007988
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Identification of methionine oxidation in human recombinant erythropoietin by mass spectrometry: Comparative isoform distribution and biological activity analysis.
    Hedayati MH; Norouzian D; Aminian M; Teimourian S; Ahangari Cohan R; Khorramizadeh MR
    Prep Biochem Biotechnol; 2017 Nov; 47(10):990-997. PubMed ID: 28825868
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Quantitative analysis of erythropoietin in human plasma by tandem mass spectrometry.
    Xuereb F; Chaignepain S; Breilh D; Godde F; Saux MC; Lenz C; Glueckmann M; Schmitter JM
    Anal Bioanal Chem; 2011 Jun; 400(7):2073-84. PubMed ID: 21445661
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine.
    Catlin DH; Breidbach A; Elliott S; Glaspy J
    Clin Chem; 2002 Nov; 48(11):2057-9. PubMed ID: 12406997
    [No Abstract]   [Full Text] [Related]  

  • 112. Isolation, enrichment, and analysis of erythropoietins in anti-doping analysis by receptor-coated magnetic beads and liquid chromatography-mass spectrometry.
    Vogel M; Blobel M; Thomas A; Walpurgis K; Schänzer W; Reichel C; Thevis M
    Anal Chem; 2014 Dec; 86(24):12014-21. PubMed ID: 25423444
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Differences in sialic acid O-acetylation between human urinary and recombinant erythropoietins: a possible mass spectrometric marker for doping control.
    Reichel C
    Drug Test Anal; 2013; 5(11-12):877-89. PubMed ID: 24353190
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Mass spectrometric analysis of EPO IEF-PAGE interfering substances in nitrile examination gloves.
    Reichel C
    Drug Test Anal; 2012 Oct; 4(10):761-74. PubMed ID: 23081906
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Serum proteomic changes after randomized prolonged erythropoietin treatment and/or endurance training: detection of novel biomarkers.
    Christensen B; Ludvigsen M; Nellemann B; Kopchick JJ; Honoré B; Jørgensen JO
    PLoS One; 2015; 10(2):e0117119. PubMed ID: 25679398
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Two-dimensional gel electrophoresis for controlling and comparing culture supernatants of mammalian cell culture productions systems.
    Wimmer K; Harant H; Reiter M; Blüml G; Gaida T; Katinger H
    Cytotechnology; 1994; 16(3):137-46. PubMed ID: 7766141
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Two-Dimensional Electrophoresis and Identification by Mass Spectrometry.
    de la Cuesta F; Alvarez-Llamas G; Barderas MG
    Methods Mol Biol; 2017; 1592():71-78. PubMed ID: 28315212
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Stability of human recombinant epoetin alfa in commonly used neonatal intravenous solutions.
    Ohls RK; Christensen RD
    Ann Pharmacother; 1996 May; 30(5):466-8. PubMed ID: 8740324
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The effect of pH, hydrogen peroxide and temperature on the stability of human monoclonal antibody.
    Usami A; Ohtsu A; Takahama S; Fujii T
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1133-40. PubMed ID: 8818025
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Proteomic approach to identify acute phase response-related proteins with low molecular weight in loach skin following injury.
    Peng X; Wu Y; Chen J; Wang S
    Proteomics; 2004 Dec; 4(12):3989-97. PubMed ID: 15468190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.